How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

Annals of Surgical Oncology - United States
doi 10.1245/s10434-016-5246-8

Related search